Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection (npj Vaccines (2018) DOI: 10.1038/s41541-018-0050-z)

Malcolm S. Duthie; Maria T. Pena; Gigi J. Ebenezer; Thomas P. Gillis; Rahul Sharma; Kelly Cunningham; Michael Polydefkis; Yumi Maeda; Masahiko Makino; Richard W. Truman; Steven G. Reed

ArticleOPEN ACCESS

Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection (npj Vaccines (2018) DOI: 10.1038/s41541-018-0050-z)

npj Vaccines

DOI: 10.1038/s41541-018-0055-7

1Citations

9Readers

Get full text

Abstract

A source of funding was mistakenly left out of the Acknowledgements. This research was also funded by NIAID/HRSA Interagency Agreement no. AAI15006-004-00000.

Cite

CITATION STYLE

APA

Duthie, M. S., Pena, M. T., Ebenezer, G. J., Gillis, T. P., Sharma, R., Cunningham, K., … Reed, S. G. (2018, December 1). Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection (npj Vaccines (2018) DOI: 10.1038/s41541-018-0050-z). Npj Vaccines. Nature Publishing Group. https://doi.org/10.1038/s41541-018-0055-7

Correction: LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection (npj Vaccines (2018) DOI: 10.1038/s41541-018-0050-z)

Abstract

Cite

Register to see more suggestions